ORTHOCON® estimates that over 3.5 million patients undergoing surgeries in the United States and Europe each year could benefit from the intraoperative use of HEMASORB.

ORTHOCON® Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty
August 23, 2012 - Click to Download
Use of this Site is subject to express Terms of Use. By using this Site, you signify that you agree to be bound by these Terms of Use, which were last revised on ,聽.
Legal 聽聽聽聽 Privacy Policy
© 2013 Abyrx, Inc. HEMASORB is a registered trademark of Abyrx, Inc.
HEMASORB apply is a trademark of Abyrx, Inc.
Abyrx, Inc. products are produced under U.S. patent 7989000. Other patents pending.